Skip to main content

Acceleron Pharma Inc

XLRNDelisted Nov 22, 2021
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001280600

Acceleron Pharma Inc was delisted on Nov 22, 2021; its insiders filed their last Form 4 on Nov 22, 2021; 333 institutions reported holding it in 13F filings for Q3 2021, worth $9.22B in total; no superinvestor held it.

Members of Congress who traded XLRN

No member of Congress has reported a trade in Acceleron Pharma Inc since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.